Medibank Private Limited
MDBPF · OTC
6/30/2025 | 12/30/2024 | 6/30/2024 | 12/30/2023 | |
|---|---|---|---|---|
| Revenue | $4,160 | $4,386 | $3,949 | $2,041 |
| % Growth | -5.2% | 11.1% | 93.5% | – |
| Cost of Goods Sold | $6,655 | $0 | $18 | $0 |
| Gross Profit | -$2,495 | $4,386 | $3,931 | $2,041 |
| % Margin | -60% | 100% | 99.5% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $879 | $0 | $0 | $0 |
| SG&A Expenses | $743 | $312 | $316 | $304 |
| Sales & Mktg Exp. | $176 | $0 | $0 | $0 |
| Other Operating Expenses | $108 | $0 | -$158 | -$152 |
| Operating Expenses | $850 | $312 | $158 | $152 |
| Operating Income | -$3,346 | $4,074 | $3,633 | $1,889 |
| % Margin | -80.4% | 92.9% | 92% | 92.6% |
| Other Income/Exp. Net | $3,581 | -$3,581 | -$3,413 | -$1,471 |
| Pre-Tax Income | $236 | $493 | $220 | $418 |
| Tax Expense | $71 | $149 | $67 | $74 |
| Net Income | $161 | $340 | -$339 | $343 |
| % Margin | 3.9% | 7.8% | -8.6% | 16.8% |
| EPS | 0.06 | 0.12 | -0.12 | 0.12 |
| % Growth | -50% | 200% | -200% | – |
| EPS Diluted | 0.06 | 0.12 | -0.12 | 0.12 |
| Weighted Avg Shares Out | 2,754 | 2,754 | 2,762 | 2,754 |
| Weighted Avg Shares Out Dil | 2,754 | 2,754 | 2,762 | 2,754 |
| Supplemental Information | – | – | – | – |
| Interest Income | $144 | $0 | $0 | $0 |
| Interest Expense | $10 | $1 | $5 | $1 |
| Depreciation & Amortization | $96 | $0 | $49 | $40 |
| EBITDA | $337 | $499 | $279 | $535 |
| % Margin | 8.1% | 11.4% | 7.1% | 26.2% |